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Abstract 
Multiple sclerosis is a chronic, neurological, autoimmune condition that is characterized by 
unpredictable demyelination of the central nervous system. Multiple sclerosis remains one of the 
most debilitating neurological diseases for young adults, affecting an average of 2.5 per 100,000 
people worldwide.  
 The objective of this research was to further assess the efficacy of non-pharmacological 
treatment methods for symptom management and disease progression for multiple sclerosis. A 
systemic literature review was conducted using 4 research databases: American Search Premier, 
Medline, Cochrane, and CINAHL. Studies were included if they addressed nonpharmacological 
treatment approaches to multiple sclerosis. A total of 21 research articles were used to assess 
inclusion or exclusion criteria. 
What the research concluded was that there was not definitive evidence to prove that any 
non-pharmacological treatment method would guarantee a decrease in disability or increase in 
overall quality of life for patients with multiple sclerosis. However this body of research did 
show that non-pharmacological interventions could provide some benefit and none of these non-
pharmacological treatment methods were harmful, thus validating the safety and potential benefit 
to be implemented in practice. Much more research needs to be conducted to look specifically at 
different nonpharmacological treatment approaches for the management of multiple sclerosis as 
varying symptoms make it difficult to pinpoint the exact benefit that each nonpharmacological 
approach may have.  
Keywords: multiple sclerosis, non-pharmacological, treatment, lifestyle modification, 
disease progression, smoking, diet, exercise 
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Impact of Non-Pharmacological Treatment Methods and Lifestyle Modification on 
Multiple Sclerosis Symptoms and Progression 
 Multiple sclerosis is a chronic autoimmune, condition that is characterized by 
inflammation and demyelination of the central nervous system (Amatya et al., 2013). Multiple 
sclerosis occurs more commonly in women. Multiple sclerosis is an autoimmune disorder that 
has an unclear etiology, and can be associated with long-term effects, complications and, 
decreased quality of life. Multiple sclerosis has the capacity to cause severe disability in those 
affected by the disease. There are different forms of multiple sclerosis, each with varying degrees 
of disability. Different forms of multiple sclerosis include relapsing remitting, primary 
progressive, and secondary progressive. Relapsing remitting forms of multiple sclerosis consist 
of periods of inflammation and exacerbation followed by periods of returning to baseline, or 
remission. Primary and secondary progressive forms of multiple sclerosis occur when a person 
slowly progress in their disease process without the ability to return to their baseline functioning 
(Amatya et al., 2013). Secondary progression typically occurs in adults after they have had 
relapsing-remitting multiple sclerosis. At this stage, the patient will continue to have relapses but 
will not experience remission. Primary progressive forms of multiple sclerosis occur initially 
when the diagnosis is not consistent with relapsing-remitting. In this form of multiple sclerosis, 
the initial disease course consists of relapse and absence of remission. Once a person has a 
diagnosis of multiple sclerosis, they typically have a prolonged life period of at least 40 more 
years. Because of this, it is likely for a person to have a prolonged disease process and 
progression of disability, making it imperative that patients with multiple sclerosis obtain 
treatment to prevent severe disability and improve quality of life (Amatya et al., 2013).  
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In recent decades, there has been a dramatic increase in the amount of effort that has been 
placed on assessing different types of treatment modalities for multiple sclerosis. Treatment for 
multiple sclerosis can come in a variety of forms. Pharmacological treatment methods have been 
extensively studied and are ever changing. However, non-pharmacological treatment approaches 
to the management of multiple sclerosis is an area of medicine that is much less researched. 
There is a variety of non-pharmacological treatment options that had been researched for 
symptom management for multiple sclerosis. The objective of this literature review is to examine 
the evidence pertaining to the efficacy of non-pharmacological treatment methods for symptom 
management and impact on the disease progression of multiple sclerosis.  
Background 
The exact cause of multiple sclerosis remains unknown however environmental and 
immunological factors may play a part. Over the past decades, there has been a rapid increase in 
the incidence and prevalence of multiple sclerosis throughout the world. Some think that this 
may be due to the change in dietary and lifestyle habits, although there is no definitive cause of 
the increasing number of patients with multiple sclerosis (Matveeva et al., 2018). Environmental 
factors that have been attributed to the development of multiple sclerosis include inadequate 
vitamin D levels, tobacco use, obesity, genetic predisposition, infection with the Epstein Barr 
virus, and geographic location (Matveeva et al., 2018). Worldwide, multiple sclerosis affects 
over 2.5 million people. Multiple sclerosis is the most present in the northern hemisphere. There 
is currently no cure for multiple sclerosis. However, measures can be implemented to help with 
symptom management. 
 Clinical manifestations for patients with multiple sclerosis can be variable and dependent 
on the person. Some of these manifestations can include vision loss, weakness, ataxia, spasticity, 
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tremors, sensory loss, cognitive impairment, and bowel and bladder dysfunction (Amatya et al., 
2013). Pharmacological methods have proven to help with symptom relief and disease 
progression. However, non-pharmacological treatment methods can also help with symptom 
management and prevention of relapses. With the increasing numbers of multiple sclerosis cases 
worldwide, there has also been an increasing interest and amount of research conducted on 
treatment options. As a result, there has been an increasing amount of evidence on non-
pharmacological treatment for prevention of multiple sclerosis progression. Much of the research 
on non-pharmacological treatment is also focused on quality of life. Some of the non-
pharmacological treatments that have been heavily researched include diet, exercise, and 
smoking cessation. When measuring the outcomes of non-pharmacological treatment, data is 
often collected from subjective report. Symptoms measured subjectively include spasticity, 
fatigue, pain relief, and overall quality of life.  
 Much of the focus on autoimmune conditions and their treatment relies on 
pharmacological management. The significance of non-pharmacological management in the 
treatment of multiple sclerosis is also gaining relevance with increasing research. Many factors 
go into treatment for multiple sclerosis, some of which are difficult to obtain due to cost and 
availability. The benefit of non-pharmacological treatment is the ease of accessibility and 
affordability for patients. With the increasing rates of patients being diagnosed with multiple 
sclerosis, there is an increased importance that is being placed on treatment options. In the 
primary care setting, management will be collaborative and based on patient preferences,  
providing education, and sharing clinical evidence. 
Recognizing the importance of managing symptoms and delaying disease progression can 
be pivotal for the health outcomes of the patients diagnosed with multiple sclerosis. When 
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assessing outcomes for non-pharmacological treatment for patients with multiple sclerosis, it is 
important to ask the questions about if treatment is effective in minimizing impairment, effective 
in minimizing the burden of care, an improving quality of life (Amatya et al., 2013). 
Clinical Question 
Based on the clinical significance of this area of interest, a Population-Intervention-Outcome 
(PIO) question was formatted to help guide a systemic literature review (Melnyk & Fineout-
Overholt, 2015). Among adults living with multiple sclerosis (P), how do non-pharmacological 
treatment methods and/or lifestyle modification (I) impact disease progression and symptom 
management (O)? The working hypothesis is that non-pharmacological treatment methods for 
multiple sclerosis will aid in symptom management and alter disease progression for patients 
who carry an established diagnosis. 
Clinical Significance for Advanced Practice 
 A multi-disciplinary approach is needed to manage care for patients with the diagnosis of 
multiple sclerosis. The modalities that are involved in treatment can be rather complex. To this 
point, multiple sclerosis remains one of the most challenging neurological diseases to understand 
and treat (Matveeva et al., 2018). There has been an increase in the amount of knowledge that is 
known about mechanisms that may trigger and drive multiple sclerosis allowing for 
individualized therapy in the advanced practice setting (Matveeva et al., 2018). Providers must 
place increased accountability on patients with multiple sclerosis for managing their care and 
engaging in positive health promoting behaviors. In the advanced practice setting, motivational 
interviewing, educating, and encouraging healthy behavior through non-pharmacological 
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approach can lead to better health outcomes and improved quality of life for patients with 
multiple sclerosis.  
Methods 
 A comprehensive literature review was conducted between 10/1/2019 and 11/15/2019. 
Databases that were selected for reviewed included Academic Search Premier (ASP), 
Cumulative Index of Nursing and Allied Health Literature (CINAHL), Medline, and Cochrane 
Database of Systematic Reviews. These databases were selected in order to provide a 
comprehensive review of the available literature. Articles were limited to full text, peer-
reviewed, and abstract available. All articles were published after the year of 2006. For 
reference, refer to Appendix A. Keywords that were used for research included “multiple 
sclerosis,” “non-pharmacological,” “treatment,” “smoking,” “exercise,” “diet,” “lifestyle,” 
“lifestyle modification,” and “disease progression.” For specific keyword combinations and 
yielded results for every database assessed, reference Appendix B. For every keyword 
combination, results were reviewed if there were 10 or less results. A total of 21 studies were 
identify as potentially pertinent to the clinical question based on review of title and abstract; 
these studies were further reviewed for inclusion and exclusion criteria.  
Inclusion and Exclusion 
 Articles that were related to non- pharmacological methods for disease management were 
included. Studies were eliminated if they focused only on pharmacological management. An 
extensive amount of research was conducted on lifestyle modifications including smoking, diet, 
and exercise. Studies that focused on psychological interventions were excluded, as these were 
more pertinent to quality of life rather than disease alteration. Another study that was often 
brought up was done over a five-day course at a residential treatment center (Hadgkiss et al., 
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2013). These studies were excluded as they were short-term and did not give indications of 
disease modification, but rather focused on quality of life. Articles that addressed non-
pharmacological methods for treatment of symptoms, such as chronic pain, fatigue, or spasticity, 
were included. All studies that only addressed quality of life as an indicator of non-
pharmacological intervention were excluded. Of the 21 studies that were  examined through 
review of the abstracts, 13 met inclusion criteria. See Appendix C for detailed information 
related to the rationale for each study that was included or excluded. See Appendix D for the data 
abstracted from the studies included in the systemic review. Each study was fully reviewed for 
findings pertinent to the clinical question.  
Literature Review 
 There have been a multitude of studies that have been completed on non-pharmacological 
treatments for multiple sclerosis. Emerging themes among the research include lifestyle 
modification of diet, exercise, and smoking cessation. Along with that, there are individualized 
studies that focus on more specific non-pharmacological treatments such as the use of 
transcutaneous electrical nerve stimulation and hyperbaric oxygen therapy. This literature review 
will identify the findings in each of these sub-categories of interest. 
Non-Pharmacological Treatments 
 Muscle spasticity is among one of the many debilitating side effects of the progression of 
multiple sclerosis. Spasticity causes things such as stiffness, spasms, or tightness in any of the 
extremities. On average 60 to 80% of patients with multiple sclerosis will experience spasticity 
at some point during their disease process (Amatya et al., 2013). Spasticity can be one of the 
leading causes of disability and instability for patients with multiple sclerosis. Long term 
complications of spasticity can include muscle contractures, pain, pressure injuries, and inability 
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to adequately perform activities of daily living. This associated symptom of multiple sclerosis is 
extremely challenging to manage. In one study, spasticity management was investigated through 
the evaluation of nine randomized control trials (Amatya et al., 2013). This study investigated 
physiotherapy, electromagnetic therapy, and transcutaneous electrical nerve stimulation as non-
pharmacological treatment methods for spasticity in patients with multiple sclerosis.  When 
training muscle spasticity, the goal for management is to create goals and rehabilitation in order 
for patients to maintain a functional quality of life (Amatya et al., 2013). Due to the risks, costs, 
access issues, and unpredictable results associated with surgical procedures to treat spasticity, 
nonpharmacological interventions are often the mainstay of treatment and management. The 
biggest barrier regarding current evidence in research related to spasticity for patients with 
multiple sclerosis is the lack of known benefits (Amatya et al., 2013). This study examined 
rehabilitation programs in the inpatient, outpatient, and in home settings. The study concluded 
that there was an extreme amount diversity in the outcomes.  
Transcutaneous Electrical Nerve Stimulation 
Amatya et al. (2013) also assessed transcutaneous electrical nerve stimulation 
intervention. There was no statistically significant difference between patients who received 
therapy versus patients who did not receive therapy and their overall report of reduction in 
muscle spasm (Amatya et al., 2013). Researchers concluded, there was not enough evidence to 
support the routine use of transcutaneous electrical nerve stimulation for the treatment of 
spasticity (Amatya et al., 2013). However, the quality of this evidence is limited due to the 
inadequate amount of studies in research that has been conducted. This study did highlight gaps 
in the literature that are present when attempting to draw conclusions from this research on non-
pharmacological treatment for spasticity (Amatya et al., 2013).     
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Hyperbaric Oxygen Therapy 
When conducting research on non-pharmacological treatment approaches to multiple 
sclerosis, one area was also mentioned that was not quite as common. This was hyperbaric 
oxygen therapy for the decrease in disease progression. This study was a meta-analysis that 
looked at hyperbaric oxygen therapy and the benefits it may have in slowing the disease process. 
A total of 9 trials were looked at in this article with a total of 504 participants (Bennett et al., 
2011). Two of the trials did show a positive result in the decreasing of multiple sclerosis 
development when using hyperbaric oxygen therapy. The remaining 7 trials reported no evidence 
of treatment effect (Bennett et al., 2011). Due to the lack of evidence there is not enough 
consistent support for the benefit of hyperbaric oxygen therapy for the treatment of multiple 
sclerosis. The cost is extremely high as well and may not be justified due to the lack of evidence. 
However given there was positive benefit seen, more research is needed to validate the routine 
use of hyperbaric oxygen therapy for multiple sclerosis (Bennett et al., 2011).    
Lifestyle Modification 
Tobacco Cessation  
Smoking tobacco and smoking cessation is a lifestyle factor that has been studied with 
multiple sclerosis. One meta-analysis of 11 studies assessed the relationship of tobacco use to 
worsening disability in multiple sclerosis patients (Heydarpour et al., 2018). Disability due to 
smoking was measured using an expanded disability status scale (EDSS) or the multiple sclerosis 
severity scale (MSSS). According to some of the research included in the meta-analysis, there 
was significant disability in patients with multiple sclerosis who smoked tobacco and some 
studies revealed no significant disability (Heydarpour et al., 2018). One of the studies that was 
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assessed in this meta-analysis looked at the pathophysiology of the respiratory system and 
patients with multiple sclerosis. This study found that patients with multiple sclerosis inevitably 
have a weakened immune systems and pulmonary function. Because of this, their lungs are also 
weekend. The study found that patients with multiple sclerosis that smoke had a significant 
reduction of CD4+ cells compared to other smokers who do not have multiple sclerosis. This 
leads to decrease clearance of smoke particles and an increase in inflammatory response due to 
smoking in patients with multiple sclerosis (Heydarpour et al., 2018).  
This meta-analysis concluded was that smoking does increase disability for patients with 
multiple sclerosis. However, it also concluded that it did not increase the risk of worsening the 
severity of multiple sclerosis (Heydarpour et al., 2018). What this means is that for patients with 
severe disability due to multiple sclerosis, smoking has a strong likelihood of making that 
disability worse. However, for patients with multiple sclerosis and no significant disability, 
smoking may not make the multiple sclerosis symptoms develop or worsen (Heydarpour et al., 
2018). Since this article was published, further studies have been conducted that assess smoking 
cessation and multiple sclerosis. However, many of these studies focus collectively on lifestyle 
change rather than isolating smoking cessation thereby revealing a gap in the research literature 
(Heydarpour et al., 2018). Along with that, there lacks a standardized way to assess disability 
due to smoking which has led to a variety of study methods related to smoking and multiple 
sclerosis.  
Diet  
Dietary modifications are another lifestyle consideration for multiple sclerosis symptoms 
that is very prevalent in research. In one study, the researcher implemented a five day residential 
workshop that promoted a low-fat, plant based, seafood, high vitamin D, omega-3 
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supplementation diet (Marck et al., 2018). The participants in the study had to have had 
experienced one relapse in the prior year. A questionnaire was used to assess dietary habits. 
After this workshop, the participants were assessed at the one year and three year mark. There 
were a total of 76 participants at the one year mark in 78 participants at the three year mark 
(Marck et al., 2018). The majority of these patients, 73%, had a diagnosis of relapsing-remitting 
multiple sclerosis What the study found was that there were improvements in health outcomes 
one year after the intervention and there was substantial and sustained improved health outcomes 
three years after the workshop. The goal of this study was to assess if lifestyle changes were 
maintainable for patients with multiple sclerosis. The study concluded that, over time, patients 
with multiple sclerosis were able to sustain healthy lifestyle choices that led to a decrease in their 
overall disability. One of the biggest limitations of this study was the small sample size as well 
as all of the data being self-reported (Marck et al., 2018).  
 One study looked at overall brain atrophy that was due to poor diet for patients with 
multiple sclerosis (Jakimovski et al., 2019). This study compared patients with multiple sclerosis 
to healthy controls. The participants in the study had to implement lifestyle-based behavior and 
their brain was imaged through MRI over a five-year period. What the study found was that 
patients with multiple sclerosis who had an unhealthy diet had a higher accrual of brain lesions 
over a five year period (Jakimovski et al., 2019). The study looked at the Mediterranean diet and 
the effects that it may have on multiple sclerosis. This diet includes fruits, vegetables, whole 
grains, and reduced sugar and red meat (Jakimovski et al., 2019). Given that poor diet was 
correlated with higher lesion accrual, and there were weaker associations with diet alcohol and 
tobacco, it could imply that there is an independent process that diet contributes to brain atrophy 
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for patients with multiple sclerosis. What this study concluded was that healthy lifestyle caused a 
decrease in brain atrophy and lesion accrual (Jakimovski et al., 2019).  
 Dietary factors and obesity have been known to play a significant role for patients with 
multiple sclerosis. In one study, the westernized diet was investigated as it may play a significant 
role in the development and worsening of multiple sclerosis. The westernized diet is high in salt, 
fatty acids, flavonoids, and saturated fats. A diet high in salt has been correlated to enhance 
disease exacerbation and new lesion development. Salt also can affect T cells which alter the 
macrophage response (Matveeva et al., 2018). This causes a suppression of the anti-
inflammatory properties that a macrophage possesses. The role that fats play in the development 
and progression of multiple sclerosis is linked to their effect on inflammation and increasing 
relapse risk (Matveeva et al., 2018). Flavonoids play a role in multiple sclerosis development in 
that the suppress monocytes and limit the uptake of myelin by macrophages. However, there is 
mixed evidence because certain flavonoids, such as scutellarin, may aid in central nervous 
system repair (Matveeva et al., 2018). What this study concluded was that more research should 
be done on the specific mechanisms that different types of food in the westernized diet may 
contribute to the development and progression of multiple sclerosis (Matveeva et al., 2018). 
Exercise 
 When assessing approaches to lifestyle modification, exercise is a topic that is often 
studied. There is extensive research examining the relationship between exercise and its effect on 
overall functioning for patients with multiple sclerosis. One study looked at formal exercise in a 
variety of exercise techniques and their ability to maintain and improve functional capacity for 
patients with multiple sclerosis (White & Dressendorfer, 2004). One of the major things that was 
assessed was muscle strength as well as mobility. Disability for patients with multiple sclerosis 
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was often related to a reduced mobility, poor balance, abnormal gait, and muscle weakness. 
Exercise and strength training can play a significant role in decreasing disability for patients with 
multiple sclerosis. Much of the research that is conducted on exercise related to multiple 
sclerosis has to do with decreasing disability and improving quality of life. Another significant 
thing to think about for patients with multiple sclerosis is their long-term use of corticosteroids. 
Corticosteroids have been shown to decrease bone density in patients with and without multiple 
sclerosis. Given that patients with multiple sclerosis are already at an increased risk of premature 
osteoporosis, bone health is very important. Strength training and resistance training can help to 
preserve bone density for patients with multiple sclerosis with the hope of decreasing the 
likelihood of osteopenia, osteoporosis, or skeletal related disability. When looking at an exercise 
program for patients with multiple sclerosis it should be carefully considered with physical 
limitation taken into consideration. Physical therapy is another option that may be used when 
formulating an exercise plan for patients with multiple sclerosis. When looking at this study, the 
biggest limitation is lack of randomized control trials comparing patients who exercise versus 
patients who do not. There is also an increase need for further research to be conducted on the 
role that specific exercise routines play in the hindering of multiple sclerosis development 
(White & Dressendorfer, 2004). 
 Another study specifically focusing on activity was conducted. The studies assessed 
walking intensity and walking activity as a mechanism for preventing progression of multiple 
sclerosis. This study used this step watch activity monitor to assess the number of steps that were 
taken by patients who have had multiple sclerosis. The study looked at step count, walking 
intensity, and walking duration (Neven et al., 2016). What this study found was that patients with 
multiple sclerosis were not meeting the recommended duration or intensity of walking every day. 
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In order to achieve benefits from walking the intensity and duration needs to be high enough 
(Neven et al., 2016). Another thing to consider for patients with multiple sclerosis is their 
potential inability to sustain walking for long periods of time. What the study concluded was that 
patients with multiple sclerosis may be active but are not active enough to have significant 
benefit from walking. The problem with this is that some patients are unable to walk for a 
sustained period due to fatigue, making them outliers in the study (Neven et al., 2016). The 
biggest drawback in the study is that it is difficult to often assess stamina for patients with 
multiple sclerosis due to other contributing factors such as fatigue. 
 Other studies assessed fatigue related to multiple sclerosis and interventions that could be 
completed to aid in the relief of fatigue. As mentioned with exercise, fatigue can be a significant 
barrier for treatment. Fatigue is very common for patients with multiple sclerosis so assessing 
daily fatigue is important when formulating an exercise plan Treating fatigue can lead to overall 
positive health benefits for patients with multiple sclerosis. In one study, aerobic exercise, 
strength, cooling methods, and yoga was shown to have a positive effect on fatigue in patients 
with multiple sclerosis (Pozzilli et al., 2006). Both depression and fatigue can negatively affect 
cognitive development for patients with multiple sclerosis. In turn, this can have a significant 
effect on quality of life. Another study thoroughly discussed pharmacological interventions to 
manage fatigue for patients with multiple sclerosis. This study also looked at 
nonpharmacological interventions such as physical exercise for the treatment of fatigue. As 
mentioned previously, this may be controversial because exercise may help with fatigue but a 
patient with multiple sclerosis may not be able to exercise due to fatigue. What the study found 
was that there was a significant lack in protocols and evidence related to the treatment of fatigue 
for patients with multiple sclerosis (Brenner & Piehl, 2016).  
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 Another study looked at positive role that lifestyle played for overall well-being for 
patients with multiple sclerosis. This study used a variety of screening tools that assessed mental 
functioning, sleep, fatigue, stress, and disability management (Strober et al., 2018). This study 
looked at overall wellness and using a holistic approach to increase overall quality of life for 
patients with multiple sclerosis (Strober et al., 2018). What the study found was that lifestyle 
habits including diet, exercise, social participation, and intellectual activities were positively 
correlated with overall well-being for patients of multiple sclerosis (Strober et al., 2018). 
Because of this, there was a decrease in overall disease burden. The biggest drawback to this 
study was that data was collected by subjective questionnaire rather than objective assessment. 
Along with that, it was a small sample size consisting of only 248 participants (Strober et al., 
2018). 
Discussion 
 Multiple sclerosis is one of the most debilitating autoimmune disorders. There has been 
an extensive amount of new research that has been conducted on different types of treatment 
options. As a result of this research there is a variety of findings based on varied methods and 
interventions studied. When conducting research on non-pharmacological treatment, topics that 
were consistently discussed included smoking, exercise, dietary, and overall healthy lifestyle. 
There were also outliers in the research that assessed different nonpharmacological treatment 
such as hyperbaric oxygen therapy and transcutaneous electrical nerve stimulation. When 
looking at multiple sclerosis, there is such an array of symptoms that a patient may experience. 
Because of this, there is an array of non-pharmacological approaches that may also be completed 
to help with those symptoms.   
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 In terms of non-pharmacological treatment, some research findings were more 
convincing than others. Healthy lifestyle in the form of smoking cessation, exercise, and dietary 
restrictions did prove to be beneficial for patients with multiple sclerosis.  Much of the studies 
that were completed on lifestyle modification concluded that, when smoking cessation, healthy 
diet, and exercise take place, a patient with multiple sclerosis was able to have some form of 
symptom relief. Although much of the research is limited, or focused on one specific area, there 
did prove to be benefit. Hyperbaric oxygen therapy is a newer area of research and has been 
beneficial to some patients though not found to be statistically significant. The common 
characteristics of these patients was that they had a definite diagnosis of multiple sclerosis, had 
not had periods of exacerbations in the past three to twelve months, had received no recent 
immunotherapy, and had no other contraindications to receiving hyperbaric oxygen therapy. 
(Heard & Bennett, 2011). Transcutaneous electrical nerve stimulation is more aimed at symptom 
management rather than disease progression or modification. Although it may help with the 
short-term symptom management, it has not been proven to provide any long-term beneficial 
effects.  
 There is still an extensive amount of research that needs to be done when assessing 
nonpharmacological treatment approaches for patients with multiple sclerosis. When looking at 
lifestyle factors, the most commonly researched areas including tobacco use, diet, and exercise, 
though there remains a significant amount of discrepancy in the research. However, when 
looking at this body of research, the one commonality was that non-pharmacological treatment 
interventions and recommended lifestyle modifications never caused worsening of symptoms or 
disease progression. Considering this, it does reveal that nonpharmacological treatment methods 
are safe, easy, cost effective, and have the potential for providing some benefit.  
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Implications for Practice 
 In the field of research for non-pharmacological treatment and lifestyle modification 
approaches to multiple sclerosis, there is still much research that needs to be completed. When 
considering recommendations, the first would be to increase research on different types of 
exercise and the benefits that it may have for decreasing disability for patients with multiple 
sclerosis as it has been proven to be beneficial. Currently, there is an array of evidence that 
provides evidence that exercise can be beneficial though not enough evidence to fully support 
one type of exercise over another. When considering walking and fatigue management, more 
research should be conducted on types of exercise that may be beneficial for patients who are 
immobile due to their high level of disability. If a patient with multiple sclerosis has significant 
disability, it is important to investigate what types of exercise may be completed by those 
patients that may be beneficial for preventing further disability and  improving quality of life.  
 The biggest problem in research for non-pharmacological treatment approaches to 
multiple sclerosis is the variety of symptoms in disability that each patient may face. There 
should be more research conducted on dietary contributions and factors that may play a part in 
the development and progression of multiple sclerosis. Much of the research that is currently 
available focuses on how to improve symptoms rather than how to prevent multiple sclerosis 
from occurring due to healthy diet, or if that is even possible.  
 Research for smoking tobacco during multiple sclerosis is abundant. Research does 
support that smoking cessation may decrease the severity of disability for patients with multiple 
sclerosis. However, it does not conclude that smoking sensation at the beginning of a multiple 
sclerosis diagnosis will alter the disease progression. More research should be conducted on the 
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overall effect that smoking tobacco has on the development and progression of multiple 
sclerosis, rather than just effect it has on the overall disability.  
 When looking at nonpharmacological treatment approaches to multiple sclerosis, the 
biggest benefit is that these interventions have not been found to be harmful for patients with 
multiple sclerosis. Exercise, lifestyle changes, and smoking sensation are beneficial in all 
patients whether they have multiple sclerosis or not. It is important to educate patients that these 
interventions may or may not aid in symptom management or disease progression of multiple 
sclerosis, but they are beneficial for improving overall health.   
Conclusion 
 Multiple sclerosis is an autoimmune, demyelinating, central nervous system disease. It 
can affect people throughout their lifetime and be detrimental to their quality of life. The field of 
research for multiple sclerosis is ever changing with new medications constantly available. 
However, at this point there is no cure for multiple sclerosis. Because of that, 
nonpharmacological treatment approaches can be used in combination with pharmacological 
treatment approaches to aid in overall quality of life and lack of disease progression.  
 There is an overall lack of evidence available supporting the use of non-pharmacological 
treatments and lifestyle modifications for multiple sclerosis. There is a gap in the literature in 
education that may be provided to patients that is concrete and evidence based. Due to the lack of 
harmful side effects, patients with multiple sclerosis should be provided with non-
pharmacological options to manage their symptoms and lessen disability while also explaining 
that they may or may not be beneficial when looking strictly at their multiple sclerosis, as well as 
educating on the possible benefits that they may experience.  
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Appendix A 
Database Search Description  
Database Restrictions Added 
to Search  
Dates included in 
database 
General Subjects 
covered by database 
Academic Search 
Premier (ASP) 
Full Text, Academic 
Journals, Peer 
Reviewed 
2006-2019 Provides citations and 
abstracts to articles, as 
well as full text of 
articles  
CINAHL Full Text, Academic 
Journals, Abstract 
Available 
2006-2019 Provides full text 
access to e-books 
about nursing and 29 
core nursing journals. 
Also provides 
citations and abstracts 
to articles, books, 
dissertations, 
proceedings, and 
other materials about 
all aspects of nursing 
and allied health 
Medline Full text, Peer 
Reviewed 
2006-2019 Provides citations and 
abstracts to articles 
covering  
Cochrane Database of 
systematic Reviews  
Full Text 2006-2019 Evidence-based data 
that contains full text 
articles, as well as 
protocols focusing on 
the effects of 
healthcare.  
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Appendix B 
Data Abstraction Process 
Key Words Hits in 
ASP 
Hits in 
CINAHL 
Hits in Medline  Hits in 
Cochrane 
“Multiple Sclerosis” 
and “Non-
pharmacological” 
8* 4* 4* 2* 
“Multiple Sclerosis” 
and “Treatment”  
5,550 1,075 71 16 
“Multiple Sclerosis” 
and “Smoking” 
130 28 613 0 
“Multiple Sclerosis” 
and “Exercise”  
921 569 1585 5* 
“Multiple Sclerosis” 
and “Diet” 
185 68 821 1* 
“Multiple Sclerosis” 
and “Treatment” and 
“Non-
pharmacological” 
8* 4* 55 0 
“Multiple Sclerosis” 
and “Lifestyle”  
214 111 345 0 
“Multiple Sclerosis” 
and “Lifestyle 
Modification” 
22 8* 36 0 
“Multiple Sclerosis”, 
“Disease Progression” 
and “Non-
pharmacological” 
1* 0 13 0 
*-Indicates articles reviewed for match with systematic review inclusion criteria 
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Appendix 3 
Characteristics of Literature Included and Excluded  
 
Reference 
 
 
Included 
or 
Excluded 
 
Rationale 
Amatya, B., Young, J., Khan, F., & 
Amatya, B. (2018). Non-
pharmacological interventions for 
chronic pain in multiple sclerosis. 
Cochrane Database of Systematic 
Reviews, (12). 
 
Included 
Non-pharmacological methods for chronic 
pain management for patients with MS 
Amatya, B., Khan, F., La Mantia, 
L., Demetrios, M., Wade, D. T., & 
Amatya, B. (2013). 
Nonpharmacological interventions 
for spasticity in multiple sclerosis. 
Cochrane Database of Systematic 
Reviews, (2). 
 
Included 
Assess the effectiveness of non-
pharmacological interventions for the 
treatment of spasticity in adults with MS 
Bennett, M. H., Heard, R., & 
Bennett, M. H. (2011). Hyperbaric 
oxygen therapy for multiple 
sclerosis. Cochrane Database of 
Systematic Reviews, (8). 
 
Included 
Hyperbaric oxygen therapy for slowing the 
disease process of MS 
Brenner, P., & Piehl, F. (2016). 
Fatigue and depression in multiple 
sclerosis: Pharmacological and non-
pharmacological interventions. Acta 
Neurologica Scandinavica 
Supplementum. 134, 47-54. 
 
Included 
Non-pharmacological approaches to 
symptom management and fatigue in 
patients with MS 
Messinis, L., Kosmidis, M. H., 
Lyros, E., & Papathanasopoulos, P. 
(2010). Assessment and 
rehabilitation of cognitive 
impairment in multiple sclerosis. 
International Review of Psychiatry, 
22(1), 22–34. 
 
Excluded 
Focuses on neurological assessment and 
cognitive rehabilitation as well as 
pharmacological treatment approaches  
Neate, S. L., Taylor, K. L., Jelinek, 
G. A., De Livera, A. M., Simpson, 
J. S., Bevens, W., & Weiland, T. J. 
 
 
Focuses on partners of people living with 
MS and their relationships. 
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(2019). On the path together: 
Experiences of partners of people 
with multiple sclerosis of the 
impact of lifestyle modification on 
their relationship. Health & Social 
Care in the Community, 27(6), 
1515–1524. 
Excluded 
Hadgkiss EJ, Jelinek GA, Weiland 
TJ, Rumbold G, Mackinlay CA, 
Gutbrod S, & Gawler I. (2013). 
Health-related quality of life 
outcomes at 1 and 5 years after a 
residential retreat promoting 
lifestyle modification for people 
with multiple sclerosis. 
Neurological Sciences, 34(2), 187–
195. 
 
 
Excluded 
Quality of life after 5-day stay at residential 
retreat where non-pharmacological 
treatment methods were implemented  
Heydarpour, P., Manouchehrinia, 
A., Beiki, O., Mousavi, S. E., 
Abdolalizadeh, A., Lakeh, M. 
Moradi, & Sahraian, M. A. (2018). 
Smoking and worsening disability 
in multiple sclerosis: A meta‐
analysis. Acta Neurologica 
Scandinavica, 138(1), 62–69. 
 
 
Included 
Meta-analysis on smoking and worsening 
disability for patients with diagnosed 
multiple sclerosis  
Jakimovski, D., Weinstock-
Guttman, B., Gandhi, S., Guan, Y., 
Hagemeier, J., Ramasamy, D. P., 
Fuchs, T., Browne, R., Bergsland, 
N., Dwywe, M., Ramanathan, M., 
Zivadinov, R. (2019). Dietary and 
lifestyle factors in multiple sclerosis 
progression: Results from a 5-year 
longitudinal MRI study. Journal of 
Neurology, 266(4), 866–875. 
 
Included 
Lifestyle risks studied over 5 year 
longitudinal study assessing lifestyle on MS 
disease progression 
Jelinek, G. A., De Livera, A. M., 
Marck, C. H., Brown, C. R., Neate, 
S. L., Taylor, K. L., & Weiland, T. 
J. (2016). Associations of lifestyle, 
medication, and socio-demographic 
factors with disability in people 
 
 
Included 
Focuses on heathy lifestyle and the 
association with disability with an 
international MS sample. Did not specify 
interventions that were made, but rather 
lifestyle modifications as a whole.  
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with multiple sclerosis: An 
international cross-sectional study. 
PLoS ONE, 11(8), 1–12. 
Marck, C. H., De Livera, A. M., 
Brown, C. R., Neate, S. L., Taylor, 
K. L., Weiland, T. J., Hadgkiss, E., 
Jelinek, G. A. (2018). Health 
outcomes and adherence to a 
healthy lifestyle after a multimodal 
intervention in people with multiple 
sclerosis: Three year follow-up. 
PLoS ONE, 13(5), 1–13. 
 
 
Included 
Assess health outcomes 3 years after 
lifestyle modification interventions 
Matveeva, O., Bogie, J. F. J., 
Hendriks, J. J. A., Linker, R. A., 
Haghikia, A., & Kleinewietfeld, M. 
(2018). Western lifestyle and 
immunopathology of multiple 
sclerosis. Annals of the New York 
Academy of Sciences, 1417(1), 71–
86. 
 
Included 
Assess the impact of the western diet on the 
progression and development of MS 
Moss, B., Rensel, M., Hersh, C., 
Moss, B. P., Rensel, M. R., & 
Hersh, C. M. (2017). Wellness and 
the Role of Comorbidities in 
Multiple Sclerosis. 
Neurotherapeutics, 14(4), 999–
1017. 
 
Excluded 
Assess the role of already existing 
comorbidities on the progression of MS 
Neven, A., Vanderstraeten, A., 
Janssens, D., Wets, G., & Feys, P. 
(2016). Understanding walking 
activity in multiple sclerosis: step 
count, walking intensity and 
uninterrupted walking activity 
duration related to degree of 
disability. Neurological Sciences, 
37(9), 1483–1490. 
 
Included 
Investigate the step count for patients with 
MS to assess the amount of time and 
intensity that patients with MS are 
exercising  
Nortvedt, M., Riise, T., & Mæland, 
J. (2005). Multiple sclerosis and 
lifestyle factors: the Hordaland 
 
Excluded 
Assess quality of life for patients with MS 
who have high BMI, smoke, or consume 
alcohol. 
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Health Study. Neurological 
Sciences, 26(5), 334–339.  
Pozzilli, C., Sbardella, E., de 
Giglio, L., & Tomassini, V. (2006). 
Treatment of multiple sclerosis-
related fatigue: Pharmacological 
and non-pharmacological 
approaches. Neurological Sciences, 
27, s297–s299. 
 
Included 
Non-pharmacological treatment for fatigue 
management compared to pharmacological 
management  
Ploughman, M., Austin, M., 
Stefanelli, M., Godwin, M., 
Ploughman, M., Austin, M., & 
Godwin, M. (2010). Applying 
cognitive debriefing to pre-test 
patient-reported outcomes in older 
people with multiple sclerosis. 
Quality of Life Research, 19(4), 
483–487. 
 
Excluded 
Qualitative cognitive debriefing study done 
via patient questionnaire looking at quality 
of life 
Reider, N., Salter, A. R., Cutter, G. 
R., Tyry, T., & Marrie, R. A. 
(2017). Potentially Modifiable 
Factors Associated with Physical 
Activity in Individuals with 
Multiple Sclerosis. Research in 
Nursing & Health, 40(2), 143–152. 
 
Excluded 
Lifestyle modifications to increase ability to 
complete physical activity  
Strober, L. B., Becker, A., & 
Randolph, J. J. (2018). Role of 
positive lifestyle activities on 
mood, cognition, well-being, and 
disease characteristics in multiple 
sclerosis. Applied 
Neuropsychology: Adult, 25(4), 
304–311. 
 
Included 
The use of adjunct lifestyle modifications 
for severity and frequency of MS relapses  
Thomas, P. W., Thomas, S., Hillier, 
C., Galvin, K., Baker, R., & 
Thomas, P. W. (n.d.). Psychological 
interventions for multiple sclerosis. 
Cochrane Database of Systematic 
Reviews, (1). 
 
Excluded 
Assess the effectiveness of psychological 
interventions for patients with MS. 
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White, L. J., & Dressendorfer, R. H. 
(2004). Exercise and multiple 
sclerosis. Sports Medicine, 34(15), 
1077–1100. 
Included Focuses on physiology alteration with 
exercise implementation in patients with 
MS 
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Appendix 4 
Literature Review Table of All Studies Included  
Citation Study 
Purpose 
Pop 
(N), 
Sample 
Size 
Design/L
evel of 
Evidence  
Variables  Findings Conclusion 
Amatya, B., 
Young, J., 
Khan, F., & 
Amatya, B. 
(2018). 
Investigate 
the 
effectivenes
s of non-
pharmacolo
gical 
therapies 
for chronic 
pain for 
patients 
with MS 
(PwMS) 
10 
Studies 
Level I 
Literature 
review of 
all 
published 
RCTs and 
CCTs  
Non-
pharmacolo
gical 
therapies 
for chronic 
pain such as 
transcutane
ous 
electrical 
nerve 
stimulation 
(TENS), 
heat or cold 
therapy, 
supportive 
braces, 
exercise, 
biofeedback
, and 
relaxation 
No 
statistically 
significant 
association 
for non-
medication 
treatment for 
chronic pain 
management 
for PwMS 
Many 
studies 
contained 
low number 
of 
participants
. More 
research 
needs to be 
conducted 
with more 
participants 
to 
determine 
effectivenes
s 
Amatya, B., 
Khan, F., 
La Mantia, 
L., 
Demetrios, 
M., Wade, 
D. T., & 
Amatya, B. 
(2013). 
Investigate 
effectivenes
s of non-
pharmacolo
gical 
therapies 
for 
spasticity 
for PwMS 
including 
TENS and 
exercise  
9 
Studies 
Level I 
RCTs 
using 
GRADE 
tool as 
meta-
analysis 
was not 
possible 
due to 
heterogen
eity of 
Non-
pharmacolo
gical 
therapies 
for 
spasticity   
No statistical 
significance 
for non-
pharmacolog
ical 
treatment for 
spasticity for 
PwMS 
Wide 
variety of 
non-
pharmacolo
gical 
methods are 
used for 
spasticity, 
but more 
through 
trials need 
to be done 
to build 
evidence 
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included 
studies  
for 
spasticity  
Bennett, M. 
H., Heard, 
R., & 
Bennett, M. 
H. (2011). 
Investigate 
efficacy 
and safety 
of 
Hyperbaric 
oxygen 
therapy for 
treatment of 
MS 
10 
studies, 
504 
particip
ants 
Level I 
RCTs 
meta-
analysis  
Hyperbaric 
oxygen 
therapy 
versus sham 
therapies 
for MS 
No statistical 
significance 
to verify a 
benefit for 
hyperbaric 
oxygen 
therapy for 
treatment of 
MS 
Hyperbaric 
oxygen 
therapy 
cannot be 
justified for 
routine 
treatment 
for MS 
Brenner P, 
Piehl F. 
(2016). 
Compare 
pharmacolo
gical versus 
non-
pharmacolo
gical 
therapy for 
fatigue and 
depression 
in PwMS 
NA Level IV 
Cohort 
Study 
Pharmacolo
gical versus 
non-
pharmacolo
gical 
treatment 
for fatigue 
and 
depression 
for PwMS 
Pharmacolog
ical 
treatment for 
fatigue is 
modest, non-
pharmacolog
ical benefit 
demonstrates 
some 
efficacy 
although not 
statistically 
significant. 
Very few 
studies are 
conducted on 
depression.  
Further 
research is 
needed to 
refine 
treatment 
protocols. 
Heydarpour
, P., 
Manoucheh
rinia, A., 
Beiki, O., 
Mousavi, S. 
E., 
Abdolalizad
eh, A., 
Lakeh, M. 
Moradi, & 
Sahraian, 
Investigate 
environmen
tal factors, 
focusing on 
smoking, to 
alter the 
physiology 
of MS 
11 
articles 
Level I 
Meta-
analysis 
Smoking 
cessation 
and 
decreased 
expanded 
disability 
status scale 
(EDSS) and 
multiple 
sclerosis 
severity 
scale 
(MSSS) 
Smoking 
increased 
EDSS 
however it 
had no effect 
on MSSS or 
T2 lesion 
volume 
Insignifican
t findings 
were 
contributed 
to a small 
number of 
studies, 
different 
study 
techniques, 
and 
variations 
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M. A. 
(2018). 
in disability 
reports. 
Jakimovski, 
D., 
Weinstock-
Guttman, 
B., Gandhi, 
S., Guan, 
Y., 
Hagemeier, 
J., 
Ramasamy, 
D. P., 
Fuchs, T., 
Browne, R., 
Bergsland, 
N., Dwywe, 
M., 
Ramanathan
, M., 
Zivadinov, 
R. (2019). 
Assess 
lifestyle 
risk factors 
linked to 
cardiovascu
lar disease 
and MS 
outcomes  
175 
PwMS 
42 
controls 
Level II 
Single 
RCT 
Followed 
patients for 
5 years, 
obtained 
baseline 
and follow-
up MRIs 
and 
assessed 
changes 
based on 
diet and 
lifestyle 
changes  
Lifestyle 
contributes 
to increased 
and 
enhanced 
brain atrophy 
in PwMS  
Lifestyle 
modificatio
ns may 
prove to be 
beneficial 
for PwMS 
and 
reducing 
the effect 
and 
potential 
for brain 
atrophy  
Marck, C. 
H., De 
Livera, A. 
M., Brown, 
C. R., 
Neate, S. L., 
Taylor, K. 
L., Weiland, 
T. J., 
Hadgkiss, 
E., Jelinek, 
G. A. 
(2018). 
Assess 
adopting 
and 
adhering to 
lifestyle 
modificatio
n 
intervention
s long-term  
95 
PwMS 
Level IV 
Cohort 
Study  
Follow 
PwMS for 1 
year and 3 
year follow-
ups from a 
5 day 
workshop 
on lifestyle 
modificatio
ns to assess 
PwMS 
physical 
and mental 
health  
Decrease in 
disability 
from 
baseline to 1-
year and 3-
year follow-
up. Fewer 
patients had 
relapses 
when 
continuing 
healthy 
lifestyle 
interventions 
Lifestyle 
modificatio
n that is 
sustainable 
is beneficial 
to PwMS. It 
may also 
decrease 
the need for 
pharmacolo
gical 
therapy 
Matveeva, 
O., Bogie, J. 
F. J., 
Hendriks, J. 
J. A., 
Study 
environmen
tal factors 
and dietary 
habits and 
NA Level V 
Meta-
Synthesis  
Assess how 
the 
westernized 
diet and 
disturbance
The 
advancement 
of molecular 
mechanisms 
that drive 
A 
westernized 
lifestyle 
contributes 
to the risk 
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Linker, R. 
A., 
Haghikia, 
A., & 
Kleinewietf
eld, M. 
(2018). 
the 
correlation 
between 
MS 
developmen
t  
s in the 
sleep 
circadian 
rhythm to 
understand 
the etiology 
of MS 
MS can lead 
to 
specialized 
dietary 
treatment 
approaches  
assessment 
for PwMS. 
However, 
more 
research is 
needed to 
increase the 
understandi
ng on why 
that occurs 
Neven, A., 
Vanderstrae
ten, A., 
Janssens, 
D., Wets, 
G., & Feys, 
P. (2016). 
Assess step 
count, 
intensity, 
and 
duration of 
walking in 
correlation 
to degree of 
disability of 
PwMS 
64 
PwMS 
Level II 
RCT 
Assess 
PwMS step 
count, 
duration 
and 
distance 
over a 
2,3,6,10,12,
14 
minute 
period 
Step count in 
PwMS was 
lower than 
the 
recommenda
tions, which 
negatively 
influenced 
disability 
scores 
PwMS 
should be 
encouraged 
to step at a 
moderate 
intensity for 
longer 
periods of 
time to 
decrease 
their degree 
of 
disability. 
Pozzilli, C., 
Sbardella, 
E., de 
Giglio, L., 
& 
Tomassini, 
V. (2006). 
Assess 
pharmacolo
gical and 
non-
pharmacolo
gical 
treatment 
approaches 
to fatigue 
caused by 
MS 
NA Level V 
Meta-
Synthesis 
Assess 
different 
pharmacolo
gical 
approaches 
to treatment 
in 
combinatio
n to non-
pharmacolo
gical 
treatment 
approaches 
Treatment 
for fatigue 
related to 
MS should 
be 
approached 
from a 
multifactoria
l perspective 
incorporating 
pharmacolog
ical and non-
pharmacolog
ical 
treatment 
approaches 
In patients 
with mild 
fatigue due 
to MS, 
yoga, 
aerobic 
exercises, 
cooling 
therapy, 
and energy 
conservatio
n are best 
paired with 
pharmacolo
gical 
treatments 
for 
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decreased 
fatigue.  
Strober, L. 
B., Becker, 
A., & 
Randolph, 
J. J. (2018). 
Assess if 
daily 
activities 
can be used 
as an 
adjunct 
therapy to 
reduce 
severity of 
MS 
symptoms 
248 
PwMS 
Level II 
RCT 
Assess if 
healthy 
nutrition, 
exercise, 
and social 
engagement 
impacts 
function for 
PwMS 
Engaging in 
positive 
lifestyle 
activities 
have positive 
effects on 
MS and 
disease 
management  
A holistic 
approach to 
treating MS 
is best as it 
considers 
varying 
aspects of 
patient 
functioning 
and helps to 
achieve the 
overall goal 
of optimal 
health for 
those living 
with MS 
using 
exercise 
and 
temperature 
control 
White, L. J., 
& 
Dressendorf
er, R. H. 
(2004). 
Investigate 
formal 
exercise 
and 
lifestyle as 
early 
treatment 
approaches 
to treatment 
for PwMS 
NA Level I 
RCTs 
Implementi
ng exercise 
programs 
that are 
designed to 
increased 
fitness, 
muscle 
strength, 
and 
mobility  
Early 
implementati
on of 
exercise for 
PwMS to 
reduce 
increased 
function 
decline  
Contrary to 
the 
previous 
belief that 
exercise 
would 
magnify 
MS related 
symptoms, 
it is now 
shown to be 
beneficial 
for PwMS 
to be active 
to promote 
better 
overall 
health and 
delayed 
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disease 
progression
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